ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Breakthrough in Hemophilia Gene Therapy – Medical News Bulletin

Continue reading

2018-01-30 Michael Zand NEWS

Gene therapy stocks slammed after scientist reveals safety concerns … – MarketWatch

Breakthrough in Hemophilia Gene Therapy
Medical News Bulletin
As factor IX deficiency stems from an underactive form of the Factor IX gene, hemophilia gene therapy (in which a more active form of the gene is inserted into a patient’s DNA, increasing factor IX production) is being explored as an alternative …

Continue reading

2018-01-30 Michael Zand NEWS

Gene therapy stocks slammed after scientist reveals safety concerns … – MarketWatch


MarketWatch

Gene therapy stocks slammed after scientist reveals safety concerns …
MarketWatch
Shares of gene therapy companies fell sharply Tuesday, after a report by a prominent scientist revealed the safety concerns that led him to resign recently from Solid Biosciences Inc.’s scientific advisory board.
New study shows severe toxicity with high-dose AAV9-based gene therapy in animal modelsEurekAlert (press release)
Gene therapy pioneer James Wilson sounds an alarm on high-dose …Endpoints News
Gene Therapy May Not Be a Viable Option for Many Patients | GENGenetic Engineering & Biotechnology News
Barron’s –STAT –Seeking Alpha
all 9 news articles »
Continue reading

2018-01-30 Michael Zand NEWS

Global Cancer Immunotherapy Market Primary and Secondary Research with Focus on Industry Size, Challenges … – Digital Journal

Digital JournalGlobal Cancer Immunotherapy Market Primary and Secondary Research with Focus on Industry Size, Challenges …Digital JournalAccording to the Global Cancer Immunotherapy Market report, the Cancer Immunotherapy Market accounted a value of … Continue reading

2018-01-30 Michael Zand NEWS

A CRISPR Future: Five Ways Gene Editing Will Transform Our World – Futurism

FuturismA CRISPR Future: Five Ways Gene Editing Will Transform Our WorldFuturismOver the past few years, CRISPR has been making headlines. Experts predict that this gene editing technology will transform our planet, revolutionizing the societies we liv… Continue reading

2018-01-30 Michael Zand NEWS

Expert Shares Insight on Immunotherapy, Emerging Strategies in Prostate Cancer – OncLive

OncLiveExpert Shares Insight on Immunotherapy, Emerging Strategies in Prostate CancerOncLive2018 may be the year that checkpoint inhibition breaks through in the treatment landscape of prostate cancer, according to David R. Wise, MD, PhD. Currently, th… Continue reading

2018-01-30 Michael Zand NEWS

National Academy of Science to Recognize Four Individuals for Cancer Breakthroughs – Targeted Oncology

Targeted OncologyNational Academy of Science to Recognize Four Individuals for Cancer BreakthroughsTargeted OncologyDuring their 155th annual meeting, to be help April 29, the National Academy of Science (NAS) will award 19 individuals for their extrao… Continue reading

2018-01-30 Michael Zand NEWS

UCL to harness Synpromics’ promotors in gene therapy collaboration – BioPharma-Reporter.com


MarketWatch

Gene therapy stocks slammed after scientist reveals safety concerns …
MarketWatch
Shares of gene therapy companies fell sharply Tuesday, after a report by a prominent scientist revealed the safety concerns that led him to resign recently from Solid Biosciences Inc.’s scientific advisory board.
New study shows severe toxicity with high-dose AAV9-based gene therapy in animal modelsEurekAlert (press release)
Gene therapy pioneer James Wilson sounds an alarm on high-dose …Endpoints News
Gene Therapy May Not Be a Viable Option for Many Patients | GENGenetic Engineering & Biotechnology News
Barron’s –Seeking Alpha
all 9 news articles »
Continue reading

2018-01-30 Michael Zand NEWS
  • 1
  • …
  • 597
  • 598
  • 599
  • 600
  • 601
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

BioPharma-Reporter.com

UCL to harness Synpromics’ promotors in gene therapy collaboration
BioPharma-Reporter.com
In gene therapy, synthetic promotors – used to regulate gene activity and precisely control protein production – deliver therapeutic genes to immune cells such as microglia, macrophages, and T-cells. Synpromics said the research collaboration provides …